Cihan Erol

4PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 04, 2026
Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).

|Nov 27, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes.

Mehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca

|May 03, 2023
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.

Seda Kahraman, Enes Erul, Mustafa Seyyar

|Feb 04, 2021
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin

Pageof 1

Frequent Collaborators

2 joint publications

Mehmet Ali Nahit Şendur

2 joint publications

Deniz Can Güven

1 joint publications

Mustafa Gürbüz

1 joint publications

Erman Akkuş